Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold
Open accessThe DOI matches its Crossref record; 54 of the 57 references it cites were found in a registry or an index.
Abstract
Recent insights into sleep apnoea pathogenesis reveal that a low respiratory arousal threshold (awaken easily) is important for many patients. As most patients experience stable breathing periods mediated by upper-airway dilator muscle activation via accumulation of respiratory stimuli, premature awakening may prevent respiratory stimuli build up as well as the resulting stabilization of sleep and breathing. The aim of the present physiological study was to determine the effects of a non-benzodiazepine sedative, eszopiclone, on the arousal threshold and the AHI (apnoea/hypopnoea index) in obstructive sleep apnoea patients. We hypothesized that eszopiclone would increase the arousal threshold and lower the AHI in patients with a low arousal threshold (0 to −15 cmH2O). Following a baseline overnight polysomnogram with an epiglottic pressure catheter to quantify the arousal threshold, 17 obstructive sleep apnoea patients, without major hypoxaemia [nadir SaO2 (arterial blood oxygen saturation) >70%], returned on two additional nights and received 3 mg of eszopiclone or placebo immediately prior to each study. Compared with placebo, eszopiclone significantly increased the arousal threshold [−14.0 (−19.9 to −10.9) compared with −18.0 (−22.2 to −15.1) cmH2O; P<0.01], and sleep duration, improved sleep quality and lowered the AHI without respiratory event prolongation or worsening hypoxaemia. Among the eight patients identified as having a low arousal threshold, reductions in the AHI occurred invariably and were most pronounced (25±6 compared with 14±4 events/h of sleep; P<0.01). In conclusion, eszopiclone increases the arousal threshold and lowers the AHI in obstructive sleep apnoea patients that do not have marked overnight hypoxaemia. The greatest reductions in the AHI occurred in those with a low arousal threshold. The results of this single night physiological study suggest that certain sedatives may be of therapeutic benefit for a definable subgroup of patients. However, additional treatment strategies are probably required to achieve elimination of apnoea.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the existing data suggest that any improvements in apnea which occur with these agents are relatively modest.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [400]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Thus, the arousal threshold has become an important therapeutic target, but its manipulation is a double-edged sword: drugs (hypnotics, sedatives) which delay arousal may allow some stabilization of breathing but may also lead to severe hypoxemia prior to arousal.”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [400]
The cited source says what the claim attributes to it.
In the citing paper
“A low arousal threshold is an important potential contributing factor to OSA pathophysiology and may represent a therapeutic target in selected patients (Eckert et al., 2011).”
From Obstructive sleep apnea: transition from pathophysiology to an integrative disease model (2022) · cites this paper as Eckert et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281704 · Cited by 10,183 · cited 1×
“OSA (obstructive sleep apnoea) is a serious condition with major cardiovascular and neurocognitive morbidity [1–3].”
BackgroundThe Triad of Sleep Apnea, Hypertension, and Chronic Kidney Disease: A Spectrum of Common Pathology
Aziz, F., & Chaudhary, K. (2017) · Cardiorenal Medicine · doi:10.1159/000450796 · Cited by 3,267
Obstructive Sleep Apnea as a Risk Factor for Stroke and Death
Yaggi, H. K., Concato, J., Kernan, W. N., Lichtman, J. H., Brass, L. M., & Mohsenin, V. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043104 · Cited by 3,004 · cited 1×
“OSA (obstructive sleep apnoea) is a serious condition with major cardiovascular and neurocognitive morbidity [1–3].”
BackgroundEEG Arousals: Scoring Rules and Examples
(1992) · Sleep · doi:10.1093/sleep/15.2.173 · Cited by 1,637
Objective Measurement of Patterns of Nasal CPAP Use by Patients with Obstructive Sleep Apnea
Kribbs, N. B., Pack, A. I., Kline, L. R., Smith, P. L., Schwartz, A. R., Schubert, N. M., Redline, S., Henry, J. N., Getsy, J. E., & Dinges, D. F. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.4.887 · Cited by 1,339
The Association between Sleep Apnea and the Risk of Traffic Accidents
Terán-Santos, J., Jimenez-Gomez, A., & Cordero-Guevara, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401104 · Cited by 1,255
Mezzanotte, W. S., Tangel, D. J., & White, D. P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115751 · Cited by 769 · cited 1×
“Most OSA patients have anatomical compromise yielding a compensatory increase in pharyngeal dilator muscle activity during wakefulness to maintain airway patency [11].”
BackgroundSelf-citationPathophysiology of Adult Obstructive Sleep Apnea
Eckert, D. J., & Malhotra, A. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200707-114mg · Cited by 719
Self-citation
Research works printed but not linked: 1
- Eckert, 2009, Defining physiological phenotypic traits in obstructive sleep apnea: avenues for novel treatment approaches, Respirology, 14, A21
Cited by
Adult obstructive sleep apnoea
Jordan, A. S., McSharry, D. G., & Malhotra, A. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60734-5 · Cited by 1,735
Self-citationDefining Phenotypic Causes of Obstructive Sleep Apnea. Identification of Novel Therapeutic Targets
Eckert, D. J., White, D. P., Jordan, A. S., Malhotra, A., & Wellman, A. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201303-0448oc · Cited by 1,173
Self-citationPhenotypic approaches to obstructive sleep apnoea – New pathways for targeted therapy
Eckert, D. J. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.12.003 · Cited by 545
Self-citationPathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
Lv, R., Liu, X., Zhang, Y., Dong, N., Wang, X., He, Y., Yue, H., & Yin, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01496-3 · Cited by 477
Obstructive sleep apnea: Current perspectives
Osman, A. M., Carter, S. G., Carberry, J. C., & Eckert, D. J. (2018) · Nature and Science of Sleep · doi:10.2147/nss.s124657 · Cited by 441
Self-citation
Metadata
- Authors
- Eckert, D. J., Owens, R. L., Kehlmann, G. B., Wellman, A., Rahangdale, S., Yim-Yeh, S., White, D. P., & Malhotra, A.
- Affiliations
- Brigham and Women's Hospital (US)
- Sleep Disorders Program, Division of Sleep Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, U.S.A.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2011-03-07
- Volume
- 120
- Issue
- 12
- Pages
- 505-514
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- PMC
- PMC3415379
- OpenAlex
- W1974089925
- Cited by
- 367
- References
- 57
- Citations by year
- 2026: 19 · 2025: 14 · 2024: 23 · 2023: 26 · 2022: 25 · 2021: 33 · 2020: 25 · 2019: 30 · 2018: 27 · 2017: 22 · 2016: 29 · 2015: 24 · 2014: 29 · 2013: 23 · 2012: 12
- FWCI
- 14.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (7k24hl093218-06, 5r01hl090897-02)
- National Heart, Lung, and Blood Institute (R01HL073146, R01-HL090897, P01HL095491, K24 HL-093218, R01HL085188, HL73146, R01-HL-090897-01A2, K24 HL 093218-01A1)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroscience of respiration and sleep
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- eszopiclone, obstructive sleep apnea, apnea-hypopnea index, hypoxemia, sleep quality, sleep duration
- MeSH terms
- Eszopiclone, Adult, Arousal, Double-Blind Method, Humans, Hypnotics and Sedatives, Piperazines, Respiration, Sleep Apnea, Obstructive, Azabicyclo Compounds
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. https://app.cochat.ai/papers/10.1042/cs20100588
- The paper
- Eckert, D. J., Owens, R. L., Kehlmann, G. B., Wellman, A., Rahangdale, S., Yim-Yeh, S., White, D. P., & Malhotra, A. (2011). Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. Clinical Science. https://doi.org/10.1042/cs20100588
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.